Product
RPT + INH
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis InfectionStatus: Completed, Estimated PCD: 2010-10-01